INTRODUCTION
============

Traditional herbal medicines have been used for the prevention and treatment for diabetes mellitus, which is claimed to be achieved through integrated effects from multiple ingredients ([@B1]). Recently, KIOM-79, a mixture of ethanol extracts from four herbs (parched *Puerariae* radix, gingered *Magnoliae* cortex, *Glycyrrhizae* radix and *Euphorbiae* radix) was developed based on the basic known function of each herb in treating diabetes ([@B2]-[@B5]). Recent studies demonstrate beneficial effects of KIOM-79 on diabetic Goto-Gakizaki rats ([@B6]). In the murine macrophages, the inhibition of NF-κB signaling by KIOM-79 was observed, suggesting an anti-inflammatory action of KIOM-79 ([@B7]). Also, KIOM-79 inhibits VEGF expression induced by high glucose or by advanced glycosylation end-products (AGEs) in human retinal pigment epithelial cells ([@B8]).

In the process of therapeutic drug development, promising candidate compounds are frequently dropped out due to their potential risk of cardiac arrhythmia caused by, for example, K^+^ channel inhibition or incomplete inactivation of Na^+^ channels ([@B9]). Such undesirable effects slow the cardiac repolarization phase, which frequently induces early after-depolarization (EAD). The changes in action potential duration (APD) are usually assessed in terms of the QT interval in the electrocardiogram (ECG). People with inherited mutations of various cardiac ion channels or treated drugs affecting cardiac ion channels show the prolongation of QT interval (long-QT syndrome, LQTS). In severe cases, the afterdepolarization induced by LQTS can trigger fatal arrhythmia, *torsade de pointes*. Although the life-threatening QT prolongation by medical drugs is relatively rare, such risk is obviously unacceptable for novel drug development ([@B9]-[@B11]). In this respect, traditional herbal medicine should be of no exception for the screening of drug-induced cardiac arrhythmia.

The action potential (AP) of cardiac ventricular myocytes is divided into five phases. In phase 0, Na^+^ current activation rapidly depolarizes the membrane. The subsequent phase 1 of slight repolarization is followed by a plateau depolarization (phase 2). The phase 2 is due to suppression of inward rectifier as well as the delayed activation of K^+^ currents like IKr and IKs. The termination of phase 2 is caused by the phase 3 repolarization to resting membrane potential, phase 4 ([@B12]-[@B14]).

The human ether-à-go-go-related gene (hERG) encodes the potassium channel that provides the major repolarizing current early in phase 3 of the cardiac action potential. Inherited LQTS are caused by loss-of-function mutations in several cardiac K^+^ channels like hERG and KCNQ1/mink (LQT1, LQT2), or disrupted fast inactivation of Na^+^ channel, SCN5A (LQT3) ([@B10], [@B11], [@B14]). In clinical practice, the drug-induced QT prolongation is most commonly caused by direct blockage of hERG channels ([@B9], [@B11], [@B14]). An incomplete inactivation of Na^+^ channels by drug compounds also causes QT prolongation ([@B10], [@B15], [@B16]).

In the present study, we investigated the effects of KIOM-79 on hERG channels expressed in HEK-293 cells. Also, we tested in rat cardiac myocytes whether the voltage-activated Na^+^ current and L-type Ca^2+^ current are affected by KIOM-79. Finally, the effects of KIOM-79 on the action potential of rabbit Purkinje fiber were examined and compared with the result of computational simulation of cardiac action potential that reflects the changes of ion channel currents observed in whole-cell patch clamp studies.

MATERIALS AND METHODS
=====================

Recording of action potentials
------------------------------

New Zealand White rabbits of either sex were deeply anesthetized with sodium pentobarbitone (50-100 mg/kg, i.p.) for the surgical removal of hearts according to the regulation of Institutional Animal Care and Use Committee (IACUC). Purkinje fibers were isolated from the left ventricles of hearts and mounted in a continuous flow (5 mL/min)-and temperature controlled (37±1℃) chamber superfused with oxygenated normal Tyrode\'s (NT) solution. The NT solution contained (mM): 143 NaCl, 5.4 KCl, 5 HEPES, 0.33 NaH~2~PO~4~, 0.5 MgCl~2~, 16.6 glucose and 1.8 CaCl~2~ at pH 7.4 with NaOH. The tissue was stimulated (2 msec duration and 1.5-2 V amplitude) by silver bipolar electrodes at frequency of 1 Hz to evoke action potentials (APs). APs were recorded using a conventional glass microelectrode with 10-30 MΩ of electrical resistance when filled with 3 M KCl. APs were recorded using Axopatch 1D (Axon Instruments, Forster City, CA, U.S.A.), and data were stored and analyzed using the pClamp 9 (Axon Instruments). Action potential duration at 50% (APD~50~) and 90% (APD~90~) of repolarization, resting membrane potential (RMP), total amplitude (TA) of maximum depolarization from RMP, and rate of maximum depolarization at phase 0 (V~max~) values were analyzed.

Culture of HEK-293 cells expressing hERG channel
------------------------------------------------

HEK293 cells stably expressing the hERG channel, a kind gift from Dr. C. January ([@B17]), were cultured in minimum essential medium (MEM) supplemented with 10% fetal bovine serum, 1 mM sodium pyruvate, 0.1 mM nonessential amino acid solution, 100 U/mL penicillin-streptomycin, 100 µg/mL streptomycin sulfate, and 100 µg/mL zeocin in an atmosphere of 95% air and 5% CO~2~. At 60-80% confluence, cells were treated with media containing 0.25% trypsin and 0.02% EDTA for 3 min, washed with fresh media, and dispensed to new plastic culture dishes. For electrophysiological recording, cells were trypsinized (30 sec) and moved to recording chamber.

Isolation of rat ventricular myocytes
-------------------------------------

Young male Sprague-Dawley rats (3 week old) were anesthetized with pentobarbitone sodium (i.p. 200 mg/kg) and injected with heparin (100 U/kg) at the same time. The heart was quickly removed and perfused quickly via the aorta onto a Langendorf retrograde perfusion apparatus. Hearts were initially perfused with NT solution (50 mL), and then perfused with a nominally Ca^2+^ free Tyrode solution (50 mL) containing 0.5 mg/mL of collagenase (Type II, Worthington, U.K.) for 15 min. Finally, this enzyme containing solution was washed out by rinsing with high K^+^, low Cl^-^ storage solution (KB solution) for 5 min. the heart was removed from the Langendorf perfusion apparatus. The ventricular tissues were then agitated and the single cardiac myocytes were isolated and stored in the KB solution at 4℃ until used in experiments.

Whole-cell patch clamp
----------------------

The isolated cells were transferred to a small chamber (0.2 mL) on the stage of an inverted microscope (IX-70, Olympus) and perfused continuously with NT solution at a rate of 10 mL/min. A glass microelectrode with a resistance of 2-2.5 MOhm was used to obtain a gigaohm seal. The conventional whole cell patch clamp technique was used to hold the membrane potential at -60 mV with a patch-clamp amplifier (EPC-9, HEKA elektronik, Germany). For each cell, the capacitance of plasma membrane was automatically analyzed by EPC-9 and used for the normalization of membrane currents. The data were filtered at 5 kHz and displayed on a computer monitor. The data was analysed using Origin (ver. 7.0, Microcal Software, Northampton, MA, U.S.A.). The high-K^+^, low-Cl^-^ storage solution had the following composition (in mM): 70 KOH, 50 L-glutamic acid, 55 KCl, 20 taurine, 20 KH~2~PO~4~, 3 MgCl~2~, 10 glucose, 10 HEPES, 0.5 EGTA at pH 7.3 adjusted with KOH. The pipette solution for recording K^+^ current contained (mM): 100 K^-^ aspartate, 25 KCl, 5 NaCl, 10 HEPES, 1 MgCl~2~, 4 Mg-ATP and 10 1,2-bis(o-aminophenoxy)ethane-N,N,N\',N\'-tetraacetic acid (BAPTA) at pH 7.2 adjusted with KOH. The pipette solution for recording Ca^2+^ and Na^+^ currents (Cs-aspartate internal solution) contained (in mM): 90 Cs-aspartate, 20 CsCl, 2 MgCl~2~, 5 Mg-ATP, 10 HEPES, 2.5 Na~2~-creatine phosphate, 10 tetraethyl-ammonium chloride (TEA-Cl), 5 Cs-EGTA with pH 7.3 adjusted with CsOH. NT solution was used as the extracellular solution perfusing the experimental bath.

Drugs and chemicals
-------------------

Preparation of KIOM-79; cortex of *Magnolia officinalis* Rehd. et Wils., radix of *Pueraria lobata* Ohwi, radix of *Glycyrrhiza uralensis* Fisch, and radix of *Euphorbia pekinensis* Ruprecht were collected from the Gansu province in China (2003), and identified by Prof. J.-H. Kim of Division of Life Science of Daejeon University. We deposited all voucher specimens at the herbarium of Korea Institute of Oriental Medicine (Nos. 1240, 2, 7, and 207, respectively). KIOM-79 was prepared as previously described ([@B7]). Briefly, equal amounts of gingered Magnoliae cortex, parched Puerariae radix, Glycyrrhizae radix, and Euphoriae Radix were mixed, pulverized, extracted in 80% EtOH and lyophilized. The 80% EtOH extract was suspended in H~2~O (2 L) and successively extracted with *n*-hexane (×3), EtOAc (×3), and *n*-BuOH (×3) to give *n*-hexane, ethyl acetate, *n*-BuOH, and water fractions (174 g), respectively. For experiments, the lyophilized KIOM-79 and its subfractions were dissolved in dimethylsulfoxide (DMSO, 10 mg/mL) with sonication (30 min), and this was used as stock solution. All the other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.).

Statistics
----------

The data is presented as the original recordings and bar graphs of the mean±SEM (for *n* tested cells or tissues). Paired or unpaired Student\'s t-test was used for the statistical analysis where appropriate. *P* value \<0.05 was considered significant.

RESULTS
=======

The representative trace of membrane potential showed that an application of 10 µg/mL of KIOM-79 increased the action potential duration (APD) and slightly decreased the amplitude of AP ([Fig. 1A](#F1){ref-type="fig"}). The effects of KIOM-79 on APD were quantified in terms of APD~90~ and APD~50~. Also, we measured the V~max~ and TA (see *Materials and methods*). The summarized results from three rabbits showed that TA and V~max~ were decreased by 10 µg/mL of KIOM-79. The APD~90~ was increased by KIOM-79 while APD~50~ was not affected ([Fig. 1B](#F1){ref-type="fig"}). The resting membrane potential (RMP) was not significantly changed by KIOM-79.

The V~max~ and TA are generally regarded to reflect the activity of Na^+^ current. Therefore, by using the whole-cell patch clamp technique, we tested the effects of KIOM-79 on the voltage-gated Na^+^ current (I~Na~) in rat ventricular myocytes. To activate I~Na~ selectively without evoking voltage-gated Ca^2+^ current, the holding voltage was clamped at -80 mV and steplike depolarization to -35 mV was applied. By this protocol, a fast inward current was recorded that inactivated almost completely within 10 msec. The activation voltage and kinetics were corresponding with the known properties of voltagegated Na^+^ current ([@B18]). An application of KIOM-79 (10 µg/mL) partially reduced the Na^+^ current to 75% of control ([Fig. 2](#F2){ref-type="fig"}).

When the membrane voltage was held at -50 mV, where most of Na^+^ channels are inactivated, the step-like depolarizations above -40 mV activated inward currents with relatively slow kinetics of activation and inactivation. The current to voltage relation (I-V curve) of the peak inward currents at various test voltages showed an inverted bell-shape ([Fig. 3](#F3){ref-type="fig"}). These properties correspond with the known characteristics of L-type Ca^2+^ channels (I~CaL~) in cardiac myocytes ([@B18]). The application of KIOM-79 (10 µg/mL) also decreased the amplitudes of Ca^2+^ current (I~Ca~) by about 20% ([Fig. 3](#F3){ref-type="fig"}).

The increase of APD~90~, i.e. delayed repolarization, in AP recordings suggested that K^+^ channels might have been inhibited by KIOM-79. Since the cardiac action potential of rabbit is relatively short (200-250 msec), I~Kr~ is the predominant player for repolarization ([@B13], [@B14]). To get precise quantitative evaluation of I~Kr~, we tested the effects of KIOM-79 on hERG channels expressed in HEK293 cells. In the whole-cell patch clamp recording with K^+^ pipette solution, the membrane voltage was depolarized from -80 to 20 mV (1 sec) and then repolarized to -50 mV (1 sec). [Fig. 4A](#F4){ref-type="fig"} shows an example of representative current traces both under control conditions and after exposure to 10 µg/mL KIOM-79. The depolarizing step pulse (20 mV) activated a time-dependent outward current (I~depol~) that was increased by KIOM-79. However, the increasing effect on I~depol~ was significant only at relatively low concentration of KIOM-79 ([Fig. 4B](#F4){ref-type="fig"}). During the repolarization phase (-50 mV), a transient outward current larger than I~depol~ was measured, and the peak amplitude of this \'tail current\' (I~tail~) was decreased by KIOM-79. [Fig. 4B](#F4){ref-type="fig"} shows a dosedependent effect of KIOM-79 (0.01-100 µg/mL) on I~depol~ and I~tail~. With 10 µg/mL of KIOM-79, the decrease of I~tail~ was only partial (70%), and this was not different from the decrease induced by 100 µg/mL of KIOM-79. The increasing effect on I~depol~ was statistically significant only at 1 µg/mL (paired t-test).

We also examined the effects of KIOM-79 on hERG current at different voltages. The amplitude of I~depol~ was normalized to the membrane area (pA/pF). The current-voltage relation (I/V curve) of I~depol~ showed a bell-shape, a well-known property of hERG ([Fig. 4C](#F4){ref-type="fig"}). The averaged I-V curve for I~depol~ obtained at 10 µg/mL of KIOM-79 is also plotted in [Fig. 4C](#F4){ref-type="fig"}. The increase of I~depol~ by KIOM-79 was observed throughout the test voltages from above -10 mV. The mean amplitudes of normalized I~tail~ (pA/pF) measured at the common repolarization voltage (-50 mV) after various levels of depolarizing voltages were plotted in [Fig. 4D](#F4){ref-type="fig"}. The I-V curve of I~tail~ shows a voltage-dependent activation of hERG channels that reached a steady-state at +30 mV. The partial decrease of I~tail~ by KIOM-79 (10 µg/mL) was observed from above 0 mV.

Because KIOM-79 seemed to have multiple effects on hERG current, we further tested the effects of KIOM-79 fractions divided by their polarity; water soluble fraction, butanol fraction, ethylacetate fraction, and hexane fraction. The water fraction showed no effect on hERG current ([Fig. 5A](#F5){ref-type="fig"}) whereas the butanol and hexane fraction exerted both I~depol~ increase and I~tail~ decrease ([Fig. 5B, D](#F5){ref-type="fig"}). Interestingly, the ethylacetate fraction selectively increased the I~depol~ without affecting the amplitude of I~tail~ ([Fig. 5C](#F5){ref-type="fig"}).

As a whole, the decreased I~tail~ of hERG was consistent with the increase of APD~90~, and the decrease of I~Na~ and I~CaL~ could explain the decrease of V~max~ and TA by KIOM-79. However, it was not clear whether the increase of I~depol~ amplitude in hERG by KIOM-79 has affected the shape of AP. Also, the quantitative correlation between changes of individual current system and the overall effects on AP are not clear. To get a speculation on this question, we exploited a computerized electrophysiology model of rabbit ventricular myocytes.

The computer simulation model used in this study is mostly based on Kyoto model ([@B19]). Since the Kyoto model was originally constructed based on the data from guinea-pig ventricle, we modified the model to fit the experimental data from rabbit ventricle. This model contains many kinds of ion channel including hERG (*I*~Kr~), Na^+^ channel (I~Na~) and Ca^2+^ channel (*I*~CaL~). The mathematical representative of hERG is as follows.

I~hERG~=G~hERG~·C~m~·(V~m~-E~K~)·(0.1·m~1~+0.9·m~2~)·hG~hERG~=0.3024·(K~o~/5.4)^0.2^C~m~=132 pF, K~o~=142 mMα~m1~=1/{20·exp(-V~m~/11.5)+5.0·exp(-V~m~/300)}β~m1~=1/{160·exp(V~m~/28.0)+200·exp(V~m~/1,000.0))+1/(2500·exp(V~m~/20)}α~m2~=1/{1,333·exp(-V~m~/13)+133.3·exp(-V~m~/300)}β~m2~=1/{10,666·exp(V~m~/28)+13,333·exp(V~m~/1,000))+1/(10,000·exp(V~m~/20)}α~h~=3.5/{5.6·exp(V~m~/15)+2.4·exp(V~m~/300)}β~h~=1/{0.067·exp(-V~m~/15)+0.63·exp(-V~m~/150)}

Among the parameters describing the kinetics of hERG activation and inactivation, a modification of parameters related to inactivation was crucial to the reproducing the effects of KIOM-79 on hERG current. To mimic the changes of recorded hERG current by KIOM-79, we shifted the voltage-dependence of opening and closing rate constants related with the inactivation process to the right by 10 mV and to the left by 30 mV, respectively. By this, the voltage-dependence of steady-state inactivation was reduced ([Fig. 6A](#F6){ref-type="fig"}), and the dual effects of KIOM-79 on I~depol~ at 20 mV and on I~tail~ at -50 mV were reproduced ([Fig. 6B](#F6){ref-type="fig"}) similar with the recordings shown in [Fig. 4A](#F4){ref-type="fig"}.

As we applied these changes in parameters (i.e. the shift of voltage-dependence of opening and closing rate constants of hERG) to the computational model of AP, it was found that APD~90~ was prolonged similar to the recording of APs ([Fig. 7A](#F7){ref-type="fig"}). In [Fig. 7A](#F7){ref-type="fig"}, the peak amplitude of AP and V~max~ were also slightly decreased because the conductance of Na^+^ current was decreased by 25% reflecting the recorded decrease of I~Na~. In the simulated result of [Fig. 7A](#F7){ref-type="fig"}, however, the slight decrease of plateau level shown in [Fig. 1A](#F1){ref-type="fig"} was not reproduced. The disparity was further resolved by considering the effect of KIOM-79 on the amplitude of I~CaL~. As we additionally reduced the conductance of I~CaL~ to 85% of control, the plateau of reconstituted AP ([Fig. 7B](#F7){ref-type="fig"}) was found to be lowered similar to that shown in [Fig. 1A](#F1){ref-type="fig"}. The degree of prolongation in APD, however, became slightly smaller than the simulated result in [Fig. 7A](#F7){ref-type="fig"}.

DISCUSSION
==========

In cardiac APs, the key players of phase 3 repolarization are I~Kr~ (rapid delayed rectifier K^+^ current) and I~Ks~ (slow delayed rectifier K^+^ current) conducted by hERG/KCNE2 and KCNQ/minK, respectively ([@B10], [@B12], [@B13]). However, in the experimental animals like rabbit, the contribution of I~Ks~ seems minor because the durations of cardiac APs are relatively short (200-250 ms).

The initial aim of this study was to evaluate the risk of KIOM-79 on cardiac action potential, i.e. drug-induced AP lengthening. Actually, the decrease of I~tail~ in hERG suggested such possibility. However, as was found in the AP measurement and also in the computer simulation, the moderate changes of hERG current induced by KIOM-79 is reflected as only weak changes of AP. Because the change in hERG amplitude was already saturated at 10 µg/mL, it is suggested that the risk of AP lengthening and early afterdepolarization by KIOM-79 would be relatively low.

The complex effects of KIOM-79 on hERG, i.e. increase of I~depol~ and decrease of I~tail~, were intriguing. Nevertheless, such complexity was not surprising considering that multiple compounds are likely to be present in this extract. The test of fractions of KIOM-79 suggested that the dual effects of KIOM-79 might be partially separated depending on the differential solubility to organic solvents display similar effects on hERG. Since the water fraction had no effect, we could exclude the polysaccharide compounds as the candidate acting on hERG channel. The hexane fraction showed dual effects, i.e. increased I~depol~ and decreased I~tail~, similar with those of KIOM-79. The butanol fraction also showed the dual effects, however, the increase of I~depol~ was significant only at 10 µg/mL. The ethylacetate fraction only increased I~depol~, and this effect was quite potent (*P* value \<0.05 at 0.1 µg/mL).

Solvent fractionation is a method to separate compounds based on their relative solubilities in two different immiscible liquids, usually water and an organic solvent. The order of polarity between the above four fractions is water (1.0) \>butanol (0.602) \>ethylacetate (0.228) \>hexane (0.009). Generally, therefore, the petroleum ether or *n*-hexane fraction contains non-polar compounds like lipids, fatty acids, essential oils, steroids or triterpenoids. The ethyl acetate fraction has higher portion of polar components than petroleum ether or *n*-hexane fraction. The *n*-BuOH fraction contains polar compounds, mainly glycosides and tannins. Evaporation of the remaining water layer leaves polar glycosides, sugars, organic acids as a viscous gum ([@B19], [@B20]). However, separation by solvent partitioning cannot be always performed in a clearcut manner; overlapping of the compounds in successive fractions is usually found ([@B19], [@B21]). In the present study, the dual effects on hERG current were commonly observed, although the potency is different, in butanol and hexane fractions. Such overlapping results might be due to the incomplete separation of effective components. Otherwise, it might suggest that multiple compounds exert similar effects on hERG channels.

In the whole-cell patch clamp recordings of isolated cardiac myocytes, we also found that the peak amplitude of I~Na~ was decreased by KIOM-79. However, due to the huge conductance of Na^+^ channels when during the upstroke phase (phase 0) of cardiac AP (reference), a partial decrease of I~Na~ (about 75% of control) induced only a slight decrease of TA and upstroke velocity (V~max~). The slight decrease of plateau potential might be due to either the decrease of I~Ca~ or the slight increase of hERG current in its depolarizing phase (I~depol~).

The screening of drug molecules for their adverse effects on cardiac ion channels is demanding but becoming accelerated by the development of automated patch clamp systems ([@B9]). Compared with the patch clamp recording, the reliable recording of cardiac action potential in the isolated tissues like Purkinje fiber is technically demanding and requires cumbersome procedure. In this respect, the application of computerized model of cardiac action potential combined with patch clamp data might provide an efficient tool to save the cost of cardiac toxicity screening of drug development ([@B22], [@B23]). This could be also valid in traditional herbal drugs where numerous effects from multiple compounds are anticipated. In this study, we confirmed satisfactory consistence of the simulated results from virtual rabbit cardiomyocyte model combined with patch clamp study and the real conventional electrode recording. Our present results might imply the potential usefulness of the computational modeling in cardiac electrophysiology.

As mentioned above, KIOM-79 is a mixture of extracts from four herbs; parched *Puerariae* radix, gingered *Magnoliae* cortex, *Glycyrrhiza* radix and *Euphorbiae* radix. Literature search shows that puerarin from *Puerariae* partially inhibits L-type Ca^2+^ channels and cardiac Na^+^ current ([@B25], [@B26]), which might explain the partial inhibition of I~Ca~ and I~Na~ by KIOM-79. Also, magnolol from *Magnoliae* cortex shows ion channel regulatory effects on maxi-K^+^ channel and Ca^2+^ channels in smooth muscle and NMDA receptors in neuronal cells ([@B27]-[@B29]). However, no previous studies have directly tested these compounds on cardiac ion channels and APs.

In summary, in this study, we examined the effect of KIOM-79 on cardiac ion channels that play critical roles in determining the parameters of APs. Partial inhibitory effects on hERG current and I~Na~ induced increase of APD~90~ and decrease of V~max~, respectively. However, such changes are relatively minute and do not cause afterdepolarization. Because less than 1 µg/mL of KIOM-79 can effectively inhibit VEGF expression and MAPK activity ([@B8]), only a moderate change of cardiac AP by 10 µg/mL of KIOM-79 suggests relative safety in terms of the drug-induced long QT syndrome in cardiac electrophysiology.

![Effect of KIOM-79 on the APs in rabbit cardiac purkinje fibers. (**A**) Representative recording of triggered APs in control and in the presence of 10 µg/mL KIOM-79 (red trace). (**B**) Bar graphs showing shortened total amplitude (TA) and rate of maximum depolarization at phase 0 (V~max~) in the presence of 10 µg/mL KIOM-79 (upper panel). APD~90~ was increased by KIOM-79 (10 µg/mL) while APD~50~ was not affected (lower panels). ^\*^*P* value \<0.05.](jkms-24-403-g001){#F1}

![Effect of KIOM-79 on voltage-gated Na^+^ current (I~Na~) in rat ventricular myocytes. (**A**) A representative trace of membrane currents in rat ventricular myocytes obtained with Cs^+^ pipette solution. A transient I~Na~ was activated with a test depolarization (-35 mV) from holding potential of -80 mV. The I~Na~ was decrease by 10 µg/mL KIOM-79 (arrow). (**B**) Summary of the effects of KIOM-79 on the peak amplitude of I~Na~. In each cell, the current amplitudes measured at the peak of current were normalized to the control amplitude and mean±SEM values were plotted (n=6). ^\*^*P* value \<0.05.](jkms-24-403-g002){#F2}

![Effect of KIOM-79 on voltage-gated L-type Ca^2+^ current (I~CaL~) in rat ventricular myocytes. (**A**) The inward currents were recorded in rat ventricular myocytes with the Cs^+^ pipette solution. A representative current obtained by depolarizing pulse from -50 to 0 mV (200 msec) is shown. KIOM-79 (10 µg/mL) slightly decreased the inward current. (**B**) To obtain the I-V curve of I~CaL~, the membrane voltage was held at -50 mV and incremental step-like pulses were from -40 to 40 mV (10 mV intervals, 200 msec duration). The amplitudes of I-V curves were decreased by 10 µg/mL KIOM-79. Each symbol represents mean±SEM of current amplitudes normalized to the cell capacitance (pA/pF, n=5). ^\*^*P* value \<0.05.](jkms-24-403-g003){#F3}

![Effects of KIOM-79 on hERG current. (**A**) Representative hERG current traces recorded from HEK293 cells before and after application of 10 µg/mL KIOM-79. The currents were recorded with a test depolarization from the holding potential of -80 to +20 mV (1 sec), with tail currents recorded upon repolarization to -50 mV for 1 sec. (**B**) Dose dependent relationship for the increase of I~depol~ (•) and the decrease of I~tail~ (○) by KIOM-79 (µg/mL): 0.1 (n=3), 1 (n=8), 10 (n=10), 100 (n=5). Each symbol represents mean±SEM of current amplitudes normalized to control currents (%). The amplitudes of I~depol~ and I~tail~ were measured at the timing indicated by downward arrows in the pulse protocol of panel (**A**). (**C**, **D**) I-V curves for I~depol~ and I~tail~ before and after application of 10 µg/mL KIOM-79. Each symbol represents mean±SEM of current amplitudes normalized to the cell capacitance (pA/pF, n=6). ^\*^*P* value \<0.05 vs. control.](jkms-24-403-g004){#F4}

![Effects of the three different fractions of KIOM-79 on hERG current. Left panels; representative current traces obtained by step like pulses same as [Fig. 4A](#F4){ref-type="fig"}. Right panels; dose dependent relationships for I~depol~ (closed circle) and I~tail~ (open circle). (**A**) No significant effect of the water extract (n=6). (**B**) Effects of butanol (BuOH) fraction demonstrating the increase of I~depol~ and the decrease of I~tail~ (n=5). (**C**) Effects of ethylacetate (EtOAC) fraction demonstrating the increase of I~depol~ while no effect on I~tail~ (n=6). (**D**) Effects of hexane fraction demonstrating the increase of I~depol~ and the decrease of I~tail~ (n=6). Each symbol represents mean±SEM of current amplitudes normalized to control currents (%). ^\*^*P* value \<0.05 vs. control.](jkms-24-403-g005){#F5}

![Computer simulation of the effects of KIOM-79 on the voltage-dependence of hERG channel activity. (**A**) A proposed change in voltage-dependence of steady-state inactivation of hERG to reproduce the effects of KIOM-79 on hERG current in [Fig. 4](#F4){ref-type="fig"}. In order to reduce the slope of the voltage-dependence of steady-state inactivation, the opening and closing rate constants were modified as follows. α~h~=1.0/{1.6\*exp(\[V~m~-10\]/17.0)+0.7\*exp(\[V~m~-10\]/300.0)}; β~h~=1.0/{0.067\*exp(-\[V~m~+30\]/17.0)+0.63\*exp(-\[V~m~+30\]/150.0)}. The voltage-dependence of opening rate constant was shifted to the right by 10 mV, while that of closing rate constant was shifted to the left by 30 mV. Note that the voltage-dependence shows a deviation from typical Boltzman distribution since there are two exponential terms in the equations describing α~h~ and β~h~. (**B**) Reconstructed hERG currents from the altered rate constants of inactivation. Altered inactivation increased the amplitude of membrane current activated by a depolarizing step from -80 mV to +20 mV, whereas it reduced the amplitude of membrane current activated by a repolarizing step from +20 to -50 mV.](jkms-24-403-g006){#F6}

![Computer simulation of the changes in AP shape by altered properties of hERG, I~Na~ and I~CaL~ channels. (**A**) Changes in AP shape by applying the altered inactivation of hERG ([Fig. 6](#F6){ref-type="fig"}) and the decrease in Na^+^-channel density (75% of control) to the computational model. By this modification, the APD~90~ of reconstructed action potential was prolonged from 208.7 to 230.7 msec, and the peak amplitude of phase 0 was decreased, similar with the results from [Fig. 1](#F1){ref-type="fig"}. (**B**) When the conductance of I~CaL~ was reduced (80% of control) in addition to the above changes in hERG and I~Na~, the plateau potential was also affected reproducing the results from the cardiac Purkinje fiber of rabbits. The degree of prolongation in APD~90~ (ΔAPD~90~=15.5 ms) was rather small compared with the results (ΔAPD~90~=22.0 msec) in (**A**).](jkms-24-403-g007){#F7}
